| Date |
Title |
| 3/27/2009 |
ASHP Advises DEA on Disposal Regulations |
| 1/29/2009 |
Society Aims to Enhance Study of Side Effect Reporting Tool |
| 1/14/2009 |
ASHP Submits Comments to FDA Regarding Sentinel Initiative |
| 12/30/2008 |
ASHP Comments to FDA on MedWatch Plus Portal |
| 12/5/2008 |
ASHP Calls for Removal of Propoxyphene From the U.S. Market |
| 6/18/2008 |
ASHP Asks State Affiliates to Pursue Delay of Troublesome NDC Requirement |
| 6/4/2008 |
ASHP Keeps Federal Government Officials in the Loop on Rural Pharmacy Issues |
| 5/29/2008 |
Medicare Claims to Be Used to Monitor Drugs for Post-Market Adverse Events |
| 5/21/2008 |
ASHP Advises FDA on Drug Supply Systems |
| 5/7/2008 |
Industry Distribution of Journal Articles Ineffective, ASHP Tells FDA |
| 4/18/2008 |
ASHP Comments on AHRQ Proposed Rule for Medical Error Reporting System |
| 3/31/2008 |
Delay of Tamper Resistant Prescription Pad Rule Ends Today |
| 2/27/2008 |
ASHP to Give Feedback on Proposed Rule for Medical Error Reporting System |
| 2/27/2008 |
Council Releases ASHP-Backed Recommendations on Drug Name Suffixes |
| 2/21/2008 |
Delay of Tamper Resistant Prescription Pad Rule Ends April 1 |
| 2/13/2008 |
A Peek into ASHP's Regulatory Affairs Playbook for 2008 |
| 2/12/2008 |
ASHP Urges FDA to Follow IOM Recommendations |
| 1/30/2008 |
FDA Denies Merck's Application for OTC Status for Statins |